Cargando…

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial

AIMS/INTRODUCTION: Our aims were to examine the add‐on effects of a sodium–glucose cotransporter 2 inhibitor, dapagliflozin, compared with existing antidiabetes treatments, on anthropometric/metabolic parameters, the levels of an endocrine regulator, fibroblast growth factor 21 (FGF21); a skeletal m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamakage, Hajime, Tanaka, Masashi, Inoue, Takayuki, Odori, Shinji, Kusakabe, Toru, Satoh‐Asahara, Noriko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232283/ https://www.ncbi.nlm.nih.gov/pubmed/31721467 http://dx.doi.org/10.1111/jdi.13179

Ejemplares similares

Beneficial Effects of Ipragliflozin on the Renal Function and Serum Uric Acid Levels in Japanese Patients with Type 2 Diabetes: A Randomized, 12-week, Open-label, Active-controlled Trial
por: Tanaka, Masashi, et al.
Publicado: (2020)

Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2α–ATF4 Pathway in Mouse Microglia
por: Inoue, Takayuki, et al.
Publicado: (2019)

A combined index of waist circumference and muscle quality is associated with cardiovascular disease risk factor accumulation in Japanese obese patients: a cross-sectional study
por: Ikeue, Kentaro, et al.
Publicado: (2022)

Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 diabetic patients
por: Inoue, Ryo, et al.
Publicado: (2017)

Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice
por: Kusakabe, Toru, et al.
Publicado: (2020)

Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer
por: Wada, Michiko, et al.
Publicado: (2021)

Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
por: Tanaka, Masashi, et al.
Publicado: (2019)

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Tanaka, Masashi, et al.
Publicado: (2020)

Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients
por: Yamakage, Hajime, et al.
Publicado: (2021)

Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study
por: Kotani, Kazuhiko, et al.
Publicado: (2015)

Analysis of time-dependent changes in the FIB4 index in patients with obesity receiving weight reduction therapy
por: Kawai, Shiori, et al.
Publicado: (2022)

Hyperglycemia and Inflammatory Property of Circulating Monocytes are Associated with Inflammatory Property of Carotid Plaques in Patients Undergoing Carotid Endarterectomy
por: Tanaka, Masashi, et al.
Publicado: (2016)

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
por: Ikeda, Asami, et al.
Publicado: (2020)

Taxifolin Suppresses Inflammatory Responses of High-Glucose-Stimulated Mouse Microglia by Attenuating the TXNIP–NLRP3 Axis
por: Iwasa, Masayo, et al.
Publicado: (2023)

Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis
por: Inoue, Takayuki, et al.
Publicado: (2023)

A Patient-Held Medical Record Integrating Depression Care into Diabetes Care
por: Satoh-Asahara, Noriko, et al.
Publicado: (2016)

FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases
por: Itoh, Nobuyuki
Publicado: (2014)

Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1
por: Tanaka, Masashi, et al.
Publicado: (2022)

Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial
por: Son, Cheol, et al.
Publicado: (2019)

Role of Myokines in Regulating Skeletal Muscle Mass and Function
por: Lee, Jong Han, et al.
Publicado: (2019)

The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan
por: Komiyama, Maki, et al.
Publicado: (2018)

Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial
por: Hata, Akiko, et al.
Publicado: (2022)

Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia
por: Suzuki, Keita, et al.
Publicado: (2022)

Relationship between the Thyroid Function and Cognitive Impairment in the Elderly in Japan
por: Furuto-Kato, Sumiko, et al.
Publicado: (2022)

Analysis of Factors That Determine Weight Gain during Smoking Cessation Therapy
por: Komiyama, Maki, et al.
Publicado: (2013)

Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation
por: Komiyama, Maki, et al.
Publicado: (2016)

Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation
por: Komiyama, Maki, et al.
Publicado: (2018)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
por: Komiyama, Maki, et al.
Publicado: (2023)

Connecting Myokines and Metabolism
por: Ahima, Rexford S., et al.
Publicado: (2015)

Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies
por: Komiyama, Maki, et al.
Publicado: (2022)

Reassessment of Urinary Aldosterone Measurement After Saline Infusion in Primary Aldosteronism
por: Kaneko, Hiroki, et al.
Publicado: (2020)

Experimental Reproduction of Dynamic Fluctuation of TSH Receptor–Binding Antibodies Between Stimulation and Inhibition
por: Tagami, Tetsuya, et al.
Publicado: (2019)

Cricothyrotomy for an Unexpected Cannot Intubate, Cannot Ventilate Situation for a Patient with Chronic Graft-Versus-Host Disease After Induction of General Anesthesia: A Case Report
por: Tanaka, Soichi, et al.
Publicado: (2023)

Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2021)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
por: Funamoto, Masafumi, et al.
Publicado: (2019)

Short-term Changes in Self-rating Depression Scale Scores after Smoking Cessation in Neurotic Patients
por: Komiyama, Maki, et al.
Publicado: (2020)

Diagnostic accuracy of the anti‐glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme‐linked immunosorbent assay
por: Murata, Takashi, et al.
Publicado: (2017)

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
por: Fuchigami, Ayako, et al.
Publicado: (2020)

Liraglutide Suppresses Obesity and Hyperglycemia Associated with Increases in Hepatic Fibroblast Growth Factor 21 Production in KKA(y) Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_msmak7rqq6cktdm8o62pls0tqm